Skip to search.
 FTSE 100 Down0.64%

More On BOI.PA



  • Warrants
  • Investment Products


News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


Boiron SA (BOI.PA)

59.99 Up 1.29(2.20%) 15 Apr 16:35
Add to Portfolio
ProfileGet Profile for:
Boiron SA
20 Rue De La Liberation
Sainte-Foy-les-Lyon, 69110
France - Map
Phone: 33 4 72 16 40 00
Fax: 33 4 78 59 69 16

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:3,007

Business Summary 

Boiron SA, a pharmaceutical company, together with its subsidiaries, engages in the development, manufacture, and marketing of nonproprietary homeopathic medicines and OTC medication specialties. It offers homeopathic medicines in two family groups, including medicines associated with precise therapeutic indications and dosage in the form of tablets, syrups, single-dose liquids, ointments, and other presentations; and medicines that do not mention a therapeutic indication or dosage in the form of tubes, granular tubes, and cellular doses. The company produces its medicines by using vegetable, animal, mineral, and chemical substances. It primarily operates in France, rest of Europe, and North America. Boiron SA was founded in 1932 and is headquartered in Sainte-Foy-les-Lyon, France.

Key Statistics

Company Websites 
Home Page
Search Yahoo! UK & Ireland for:
More on Boiron SA

Key Executives 
Mr. Philippe Gouret , 58
Chief Pharmacist, Director of Production & Distribution and Deputy Gen. Mang.
Mr. Bruno Grange , 61
Financial Controller, Director and Member of Compensation Committee
Mr. Christian Boiron , 66
Gen. Mang. and Director
Ms. Valerie Poinsot , 45
Director of Devel. & Research and Deputy Gen. Mang.
Fabrice Rey ,
Group Treasurer
Amounts are as of 31 Dec 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year.
Currency in EUR.